GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com

Published on 3 Jun 2024 on Investing.com

Analysts indicated that GSK's potential liability from the litigation could exceed the $2 billion to...

Read the rest of the article

Start tracking your investments with Statfolio

(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongs...

Bloomberg via Yahoo Finance 3 Jun 2024

Analysts indicated that GSK's potential liability from the litigation could exceed the $2 billion...

Investing.com 3 Jun 2024

Amidst a backdrop of rising inflation and economic uncertainty across Europe, the French market h...

Simply Wall St. via Yahoo Finance 3 Jun 2024

Growth stocks can be millionaire-makers and the same ideas can be destroyers of wealth. The...

InvestorPlace 1 Jun 2024

Sanofi SNY and Regeneron REGN announced that the FDA extended the review period for a regulatory ...

Zacks via Yahoo Finance 31 May 2024

This week, J&J JNJ and Merck MRK announced proposed acquisitions of private biotech companies. Th...

Zacks via Yahoo Finance 31 May 2024

A syringe prepared for the flu vaccination of a pregnant woman with the vaccine "Vaxigrip Tetra" ...

dpa international via Yahoo Finance 31 May 2024

Shares of Insmed INSM more than doubled in market value on Tuesday after reporting positive topli...

Zacks via Yahoo Finance 29 May 2024

Johnson & Johnson JNJ announced a definitive agreement with Swiss biotech Numab Therapeutics to a...

Zacks via Yahoo Finance 29 May 2024

In recent trading sessions, France's CAC 40 Index has experienced a modest decline of 0.89%, refl...

Simply Wall St. via Yahoo Finance 29 May 2024